Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03651206
Title Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib (ROCSAN)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors ARCAGY/ GINECO GROUP
Indications

ovarian carcinosarcoma

uterine carcinosarcoma

Therapies

Paclitaxel + Pegylated liposomal-doxorubicin + Topotecan

Doxorubicin + Gemcitabine + Paclitaxel

Niraparib

Dostarlimab-gxly + Niraparib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.